The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …

Human T-lymphotropic virus 1 (HTLV-1) has infected human beings for thousands of years,
but knowledge about the infection and its pathogenesis is only recently emerging. The virus …

A study was conducted in Lima, Peru to determine if patients with Strongyloides
hyperinfection had human T cell lymphotropic virus type-1 (HTLV-I) infection. The study …

Human T-lymphotropic virus type 1 (HTLV-1) infection may cause serious disease, while
pathogenicity of HTLV-2 is less certain. There are no screening or surveillance programs for …

Background. Human T cell lymphotropic virus type 1 (HTLV-1) is associated with tropical
spastic paraparesis (TSP). Peru is an area of endemicity for HTLV-1. Methods. All patients …

Objective: To assess the seroprevalence and risk factors for HTLV-I infection in Peruvian
women. Methods: Five hundred and sixty-eight healthy women> 20 years of age from three …

The first human retrovirus, human T-cell lymphotropic virus type I (HTLV-I), was
simultaneously discovered in the United States and Japan in 1980 and associated with adult …

HIV pre-exposure prophylaxis (HIV-PrEP) is effective in reducing the likelihood of HIV
acquisition in HIV-negative people at high risk of exposure. Guidelines recommend testing …

Isolates cases and groups of patients co-infected with human T cell lymphotropic virus type I
(HTLV-I) and Norwegian scabies have been previously reported. Peru is considered to be …

This narrative review, which is based on a systematic literature search following the PRISMA
guidelines, provides a general overview of Human T‐cell Lymphotropic Virus type 1 (HTLV …